These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes. Bojestig M; Nystrom FH; Arnqvist HJ; Ludvigsson J; Karlberg BE J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):353-6. PubMed ID: 11967822 [TBL] [Abstract][Full Text] [Related]
11. Relationship between urinary sodium excretion and serum aldosterone in patients with diabetes in the presence and absence of modifiers of the renin-angiotensin-aldosterone system. Libianto R; Jerums G; Lam Q; Chen A; Baqar S; Pyrlis F; Macisaac RJ; Moran J; Ekinci EI Clin Sci (Lond); 2014 Jan; 126(2):147-54. PubMed ID: 23875766 [TBL] [Abstract][Full Text] [Related]
12. Increased red cell sodium lithium countertransport activity, total exchangeable sodium, and hormonal control of sodium balance in normoalbuminuric type 1 diabetes. Winocour PH; Catalano C; Thomas TH; Wilkinson R; Alberti KG Diabet Med; 1993 Nov; 10(9):825-32. PubMed ID: 8281727 [TBL] [Abstract][Full Text] [Related]
13. [Activity of the renin-angiotensin-aldosterone system in euglycemic type I diabetic patients on intensive insulin treatment without diabetic neuropathy]. Strojek K; Grzeszczak W; Lacka B; Górska J; Morawin E; Krywult D Pol Arch Med Wewn; 1995 Sep; 94(3):208-13. PubMed ID: 8596757 [TBL] [Abstract][Full Text] [Related]
14. An evaluation of renin-angiotensin system markers in youth with type 2 diabetes and associations with renal outcomes. Dart AB; Wicklow B; Scholey J; Sellers EA; Dyck J; Mahmud F; Sochett E; Hamilton J; Blydt-Hansen T; Burns K Pediatr Diabetes; 2020 Nov; 21(7):1102-1109. PubMed ID: 32657529 [TBL] [Abstract][Full Text] [Related]
15. Associations between glycaemic control and activation of the renin-angiotensin-aldosterone system in participants with type 2 diabetes mellitus and hypertension. Griffin TP; Wall D; Browne GA; Dennedy MC; O'Shea PM Ann Clin Biochem; 2018 May; 55(3):373-384. PubMed ID: 28814103 [TBL] [Abstract][Full Text] [Related]
16. Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Yip JW; Jones SL; Wiseman MJ; Hill C; Viberti G Diabetes; 1996 Dec; 45(12):1729-33. PubMed ID: 8922358 [TBL] [Abstract][Full Text] [Related]
17. Activity of the unstimulated renin-angiotensin-aldosterone system in type 1 diabetic patients with and without proteinuria. O'Donnell MJ; Lawson N; Barnett AH Diabet Med; 1989 Jul; 6(5):422-5. PubMed ID: 2527679 [TBL] [Abstract][Full Text] [Related]
18. The prevalence of micro-albuminuria and glomerular hyperfiltration in young patients with IDDM. Kalk WJ; Osler C; Taylor D; Panz VR; Esse JD; Reinach SG Diabetes Res Clin Pract; 1990 Jan; 8(2):145-53. PubMed ID: 2307092 [TBL] [Abstract][Full Text] [Related]
20. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment. Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]